Smaller and sharper: Nanoscale Metal-Organic Frameworks (NMOFs) as MRI Contrast Agents

Jul 08, 2010

(PhysOrg.com) -- Developing more sensitive methods of biomedical imaging that are effective with minimal amounts of contrast agents is an important challenge in the early and accurate diagnosis of illnesses.

A new class of materials that appear promising in this quest were introduced in 2006 by Prof. Wenbin Lin of the University of North Carolina at Chapel Hill. Ever since, this emerging area has been growing rapidly as new materials with improved properties are discovered. Wenbin Lin and Joseph Della Rocca present the progress in this field in the Microreview published in the European Journal of Inorganic Chemistry.

(MRI) is a noninvasive technique based on the detection of nuclear spin reorientations in a magnetic field, which, however, is relatively insensitive and typically relies on large doses of administered to distinguish adequately between normal and diseased tissues.

Nanoscale Metal-Organic Frameworks (NMOFs) are combinations of metals and on the nanoscale that provide unlimited possibilities for designing task-specific molecules. They are intrinsically biodegradable, and their high porosity makes them ideal for targeted delivery of entrapped agents. They can be specifically targeted to certain regions of the body. In addition to a wealth of applications in other fields, these properties make NMOFs also very suitable for use in biological systems and in particular as more effective contrast agents at lower doses. In addition to Gd carboxylate materials, NMOFs based on Fe, Mn, and Zn were investigated.

Coatings such as amorphous silica, biocompatible polymers, and polyoxometalate-peptide hybrid spheres were used to enhance the stability, dispersibility, and of NMOFs. Furthermore, some systems doped with lanthanides were studied as potential multimodal contrast agents.

The in vivo and in vitro effectiveness of these agents has been demonstrated. For example, iron carboxylate NMOFs modified with biocompatible polymers were used for imaging the liver and spleen of Wistar rats. Silica-coated, peptide-targeted Mn NMOFs were shown to be selectively taken up by a human colon cancer cell line in vitro. Finally, a versatile iron carboxylate system post-synthetically modified to contain a fluorophore or a chemotherapeutic showed strong fluorescence upon release from the framework and exhibited cytotoxicity comparable to cisplatin against colon cancer cells.

Explore further: Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals

More information: Wenbin Lin, Nanoscale Metal-Organic Frameworks: Magnetic Resonance Imaging Contrast Agents and Beyond, European Journal of Inorganic Chemistry, dx.doi.org/10.1002/ejic.201000496

add to favorites email to friend print save as pdf

Related Stories

Self-Assembling Nanoparticles Image Tumor Cells

Jul 23, 2007

By taking advantage of the full range of ways in which molecules can interact with and bind to one another, a team of investigators at the Carolina Center of Cancer Nanotechnology Excellence has created nanoparticles that ...

Using nano-magnets to enhance medical imaging

Feb 01, 2007

Nanoscale magnets in the form of iron-containing molecules might be used to improve the contrast between healthy and diseased tissue in magnetic resonance imaging (MRI)—as long as the concentration of nanomagnets ...

Nanoparticles Designed for Dual-Mode Imaging

Dec 18, 2006

Nanoscale, inorganic fluorescent imaging agents such as quantum dots have become an important tool for researchers studying key biomolecules involved in cancer. At the same time, magnetic iron oxide nanoparticles are proving ...

FDA wants MRI contrast agent warning

May 23, 2007

The U.S. Food and Drug Administration wants a warning printed on the labels of all gadolinium-based magnetic resonance imaging contrast agents.

Recommended for you

User comments : 0